Production (Stage)
Integrated Biopharma, Inc.
INBP
$0.292
$0.0020.69%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.25M | 928.00K | 430.00K | 112.00K | -116.00K |
| Total Depreciation and Amortization | 1.26M | 1.26M | 1.24M | 1.22M | 1.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 775.00K | 659.00K | 525.00K | 354.00K | 330.00K |
| Change in Net Operating Assets | -2.00M | -531.00K | -1.91M | -744.00K | -1.47M |
| Cash from Operations | 1.29M | 2.32M | 287.00K | 943.00K | -57.00K |
| Capital Expenditure | -347.00K | -576.00K | -571.00K | -553.00K | -425.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 1.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -347.00K | -576.00K | -571.00K | -553.00K | -424.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -18.00K | -28.00K | -39.00K | -42.00K | -41.00K |
| Issuance of Common Stock | 18.00K | 18.00K | 0.00 | 13.00K | 13.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | -10.00K | -39.00K | -29.00K | -28.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 941.00K | 1.73M | -323.00K | 361.00K | -509.00K |